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ABSTRACT  
The present investigation was aimed to prepare matrix type controlled release tablets of Glipizide with Abelmoschus 
esculentus fruit mucilage and Povidone. The polymers were studied for its functionality as a matrix forming property 
to sustain the Glipizide release from the dosage form. Physicochemical properties of dried powdered mucilage of 
Abelmoschus  esculentus  fruit  mucilage  and  Povidone  blend  were  studied.  Various  formulations  of  Glipizide 
Abelmoschus esculentus fruit mucilage and Povidone were prepared. The prepared tablets were found to have better 
pharmacopoeial parameters with low standard deviation values. The swelling behavior and release rate characteristics 
were  studied.  The  in-vitro  dissolution  study  proved  that  the  dried  Abelmoschus  esculentus  fruit  mucilage  and 
Povidone in combination can be used as a matrix forming polymers for making controlled release matrix tablets. 
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INTRODUCTION 
Abelmoschus esculentus (Malvaceae family) is an annual 
or perennial climber, growing up to 2 m tall. The fruit is 
a capsule up to 18 cm long.
1 
Glipizide  is  an  oral  hypoglycemic  agent,  which  is  a 
commonly prescribed drug for the treatment of patients 
with type II diabetes mellitus.
2 Glipizide is a weak acid 
(pKa = 5.9) which is practically insoluble in water and 
acidic  solutions  but  as  per  the  Biopharmaceutical 
Classification System (BCS) it is highly permeable (class 
2). The oral absorption is uniform, rapid and complete 
with a bioavailability of nearly 100% and an elimination 
half-life of 2–4 h.
3 Glipizide is reported to have a short 
biological  half-life  (3.4  ±  0.7  h  )  requiring  it  to  be 
administered in 2 to 3 doses of 2.5 to 10 mg per day. 
Hence we have selected Glipizide for the development of 
once  daily  controlled  release  matrix  tablets.  The 
pharmacokinetics  and  dosage  schedule  supports  once 
daily  controlled  release  formulations  for  Glipizide  for 
better  control  of  blood  glucose  levels  to  prevent 
hypoglycemia,  enhance  clinical  efficacy  and  patient 
compliance. 
The objective of present investigation is to prepare and 
evaluate  controlled  release  tablets  of  Glipizide  using 
Abelmoschus  esculentus  fruits  mucilage  and  Povidone 
combination as release retardant for making controlled 
release matrix tablets. 
MATERIALS AND METHODS 
Materials 
Glipizide  was  obtained  as  a  gift  sample  from  Dr. 
Reddy’s  Laboratories,  Hyderabad,  India.  Abelmoschus 
esculentus fruits were collected from plants growing in 
local  areas  of  Anantapur,  India.  The  plant  was 
authenticated  at  the  Botany  Department  of  Sri 
Krishnadevaraya  University,  Anantapur,  India. 
Povidone,  Micro  crystalline  cellulose  (Avicel)  and 
Magnesium  stearate  were  procured  from  SD  Fine 
chemicals  (Mumbai,  India).  All  other  chemicals  used 
were  of  analytical  reagent  grade  and  double  distilled 
water was used throughout the experiments. 
Extraction of Mucilage 
The fresh Abelmoschus esculentus fruits were collected 
and  washed  with  water.  The  fruits  were  crushed  and 
placed in water for 5–6 h, boiled for 30 minutes and left 
to stand for 1 h to allow complete release of the mucilage Suma Padmaja B et al / IJRAP 2011, 2 (2) 592-596 
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into the water. The mucilage was extracted using a multi 
layer  muslin  cloth  bag  to  remove  the  marc  from  the 
solution.  Acetone  (in  the  quantities  of  three  times  the 
volume  of  filtrate)  was  added  to  precipitate  the 
mucilage
4. The mucilage was separated, dried in an oven 
at  40
0C,  collected,  powdered,  passed  through  a  #  80 
sieve and stored in air tight container till use.  
Drug-Excipient Compatibility Studies 
Differential Scanning Calorimetric (DSC) Analysis 
DSC analysis was performed using Shimadzu DSC-60, 
Japan. A 1:1 ratio of drug and excipient was weighed 
into  aluminum  crucible.  The  sample  was  analyzed  by 
heating at a scanning rate of 20
0C over a temperature 
range 40
0-200
0C under nitrogen environment. 
Fourier  Transform  Infrared  (FTIR)  Spectroscopic 
Analysis 
FTIR  spectra  were  recorded  on  samples  prepared  in 
potassium  bromide  (KBr)  disks  using  a  Shimadzu 
Corporation,  (FTIR-1601  PC,  Tokyo,  Japan).  Samples 
were prepared in KBr disks by means of a hydrostatic 
press at 6-8 tons pressure. The samples were scanned at 
wavelength 500 to 4000 cm
-1. 
Flow Properties of Formulation Blend 
The formulation blend was evaluated for flow properties 
viz., Angle of repose, Loose Bulk Density, Tapped Bulk 
Density, Compressibility index and Hausner’s ratio. The 
experiments were conducted in triplicate.  
Preparation of Matrix Tablets 
Controlled  release  matrix  tablets  of  Glipizide  with 
Abelmoschus  esculentus  fruit  mucilage  and  Povidone 
were prepared by using different drug: mucilage ratios as 
shown  in  Table  2,  Abelmoschus  esculentus  fruits 
mucilage  and  Povidone  were  used  as  matrix  forming 
materials  while  microcrystalline  cellulose  as  a  diluent 
and Magnesium stearate as a lubricant
5. All ingredients 
used were passed through a # 100 sieve, weighed and 
blended. The granules were prepared by wet granulation 
technique  and  compressed  by  using  10  mm  flat  faced 
punches. The compositions of formulations were showed 
in Table 2. These matrix tablets were evaluated for their 
physical  properties  as  per  official  and  Pharmacopoeial 
methods
6-8 which were shown in Table 3.  
Swelling Behavior of Matrix tablets   
The  extent  of  swelling  was  measured  in  terms  of  % 
weight  gain  by  the  tablet.  The  swelling  behavior  of 
formulation GPA-1, GPA-2, GPA-3, GPA-4 and GPA-5 
were studied. One tablet from each formulation was kept 
in a Petri dish containing phosphate pH 7.4. At the end of 
2 h, the tablet was withdrawn, kept on tissue paper and 
weighed, repeated for every 2 h till the end of 12 h.
9 The 
% weight gain by the tablet was calculated by eq. 1.  
 
 S.I = {(Mt-M0) / M0} X 100  (1) 
Where, S.I = Swelling Index, Mt = Weight of tablet at 
time ‘t’ and 
Mo = Weight of tablet at time 0. Swelling behavior of 
Controlled release matrix tablets were represented in Fig. 
7. 
In vitro Drug Release Studies 
Release of Glipizide from the matrix tablets was studied 
in  phosphate  buffer  of  pH  7.4  (900  ml)  using  United 
States Pharmacopoeia (USP) 6-station Dissolution Rate 
Test Apparatus (Model Electro lab, TDT- 06T, Mumbai, 
India) with a rotating paddle stirrer at 50 rpm and 37 ± 
0.5
0C. A sample of Glipizide matrix tablets equivalent to 
10  mg of Glipizide was used  in each test. Samples of 
dissolution fluid were withdrawn through a filter (0.45 
μm) at different time intervals and were assayed at 223 
nm  for Glipizide  content
10 using  a UV/  visible  single-
beam  spectrophotometer-117  (Systronics  Corporation, 
Mumbai,  India).  The  drug  release  experiments  were 
conducted in triplicate (n = 3). The in vitro release rates 
were showed in Fig. 8. 
RESULTS AND DISCUSSION 
The  DSC  of  Glipizide  Pure  drug,  Abelmoschus 
esculentus  fruits  mucilage  with  Povidone  and  physical 
mixture  were  shown  in  Fig  1,  2  and  3  respectively. 
Infrared  Spectrum  of  Glipizide  Pure  drug,  Infrared 
Spectrum  of  Abelmoschus  esculentus  fruits  mucilage 
with  Povidone,  Infrared  Spectrum  of  formulation  was 
obtained.  The  FTIR  spectrums  revealed  that  the 
formulation spectrum retains the peaks of Glipizide and 
these  spectrums  were  represented  in  Fig.  4,  5  and  6 
respectively. 
The  Angle  of  repose  of  formulated  blend  was 
29.45
0±1.68  indicating  good  flow,  The  Loose  Bulk 
Density was found to be 0.578±0.08 g/ml, Tapped Bulk 
Density  was  found  to  be  0.788±0.03  g/ml, 
Compressibility  index  was  ranged  from  26.59±0.21% 
and Hausner’s ratio was found to be 1.24±0.04. All these 
values were shown in Table 1. The formulated tablets 
showed uniformity in swelling and the values plotted and 
shown in Fig.7. The thickness of formulated tablets were 
ranged  from  5.7±0.23  to  6.2±0.19  mm,  hardness  was 
ranged from 5.85±1.55 to 7.56±0.52 kg/cm
2, the loss on 
friability was ranged from 0.19±0.04 to 0.80±0.01 % and 
drug content was ranged from 99.1±3.66 to 100.8±6.37 
%. All these values were shown in Table 3. In vitro drug 
release  profile  of  Glipizide  from  formulated  matrix 
tablets  were  studied  using  zero  order,  first  order, 
Higuchi,  Korsmeyer  Peppa’s  and  Hixson-Crowell’s 
Models which were shown in Fig. 8, 9, 10, 11 and 12 
respectively. The rate of release was faster in GPA-1 and 
slower in GPA-5. The kinetic plots were perfectly fitting Suma Padmaja B et al / IJRAP 2011, 2 (2) 592-596 
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to  the  formulated  Abelmoschus  esculentus  fruits 
mucilage, Povidone - Glipizide matrix tablets. This result 
shown that as the proportion of Abelmoschus esculentus 
fruits mucilage and Povidone increased, the overall time 
of release of the drug  from the  matrix tablet was also 
increased.  Drug  releases  from  matrix  tablets  were  by 
drug  dissolution,  drug  diffusion  or  a  combination  of 
both.  
CONCLUSION 
The present study revealed that Abelmoschus esculentus 
fruits mucilage and Povidone combination appears to be 
suitable for use as a release retardant in the manufacture 
of controlled release matrix tablets because of its good 
swelling,  good  flow  and  suitability  for  matrix 
formulations.  From  the  dissolution  study,  it  was 
concluded  that  dried  Abelmoschus  esculentus  fruits 
mucilage  can  be  used  as  an  excipient  for  making 
controlled release matrix tablets.  
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Table 1: Flow properties of formulation blend 
 
Parameters  Value 
Angle of repose (
0)  29.45±1.68 
Loose Bulk Density (g/ml)  0.578±0.08 
Tapped Bulk Density (g/ml)  0.788±0.03 
Compressibility index (%)  26.59±0.21 
Hausner’s ratio  1.24±0.04 
Number of experiments (n)= 3 
 
Table 2: Formulae of matrix tablets 
 
Ingredients (mg)  Formulations 
GPA-1  GPA-2  GPA-3  GPA-4  GPA-5 
Glipizide  10  10  10  10  10 
Abelmoschus esculentus fruits mucilage  2  4  6  8  10 
Povidone  2  4  6  8  10 
Micro crystalline cellulose (Avicel)  181  177  173  169  165 
Magnesium stearate  5  5  5  5  5 
Total weight of tablet  200  200  200  200  200 
 
Table 3: Physical properties of formulated matrix tablets 
 
Sl. No  Formulation 
code 
Thickness 
(mm) 
Hardness 
(kg/cm
2) 
Friability 
(%) 
Drug content 
(%) 
1  GPA-1  5.9±0.19  6.52±1.04  0.70±0.08  99.8±7.51 
2  GPA-2  5.8±0.48  7.52±1.18  0.80±0.01  100.8±6.37 
3  GPA-3  5.7±0.23  5.85±1.55  0.19±0.04  99.9±5.81 
4  GPA-4  6.1±0.16  7.56±0.52  0.53±0.04  99.1±3.66 
5  GPA-5  6.2±0.19  6.92±0.29  0.64±0.01  100.4±2.55 
Number of trials (n)  = 5 
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